Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Clinical trial NCT03583125 · UNKNOWN
Trial details
- NCT number
- NCT03583125
- Sponsor
- Taizhou EOC Pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2020-02-29
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.